We are live on ! Find out more
QGENF

QIAGEN NV
QGENF

Delisted

QGENF was delisted on the 14th of February, 2005.

166 hedge funds and large institutions have $2.27B invested in QIAGEN NV in 2014 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 65 increasing their positions, 54 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $1.06M | Put options by funds: $456K

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

32% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 19

20% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 54

1% more funds holding

Funds holding: 165166 (+1)

9% less capital invested

Capital invested by funds: $2.5B → $2.27B (-$233M)

Holders
166
Holders Change
+1
Holders Change %
+0.61%
% of All Funds
4.79%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
25
Increased
65
Reduced
54
Closed
19
Calls
$1.06M
Puts
$456K
Net Calls
+$603K
Net Calls Change
-$124K
Name Holding Trade Value Shares
Change
Change in
Stake
Primecap Management
1
Primecap Management
California
$469M +$60.1M +2,848,560 +15%
HL
2
Harding Loevner
New Jersey
$147M -$742K -35,169 -0.5%
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$120M +$2M +94,688 +2%
Credit Agricole
4
Credit Agricole
France
$107M -$55.8M -2,643,681 -34%
Norges Bank
5
Norges Bank
Norway
$102M -$2.34M -111,512 -2%
BFA
6
BlackRock Fund Advisors
California
$93.4M +$3.67M +173,815 +4%
MNA
7
Manning & Napier Advisors
New York
$93M -$39.7M -1,883,140 -30%
HJGA
8
Hardman Johnston Global Advisors
Connecticut
$78.5M +$4.7M +222,803 +6%
Deutsche Bank
9
Deutsche Bank
Germany
$71.9M -$10.5M -496,518 -13%
CRM
10
Cramer Rosenthal McGlynn
Connecticut
$71.4M +$6.75M +319,835 +10%
First Trust Advisors
11
First Trust Advisors
Illinois
$50.7M +$6.38M +302,458 +14%
Swiss National Bank
12
Swiss National Bank
Switzerland
$47.9M -$2.42M -115,423 -5%
State Street
13
State Street
Massachusetts
$47.1M +$427K +20,234 +0.9%
BIT
14
BlackRock Institutional Trust
California
$44.3M +$35.8K +1,696 +0.1%
DCLA
15
Douglas C. Lane & Associates
New York
$41M +$1.08M +51,035 +3%
CS
16
Credit Suisse
Switzerland
$37.8M +$6.81M +322,895 +22%
PIM
17
Platinum Investment Management
Australia
$37.6M
Aviva
18
Aviva
United Kingdom
$33.6M -$645K -30,700 -2%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$29.4M -$1.46M -69,280 -5%
GP
20
GLG Partners
United Kingdom
$28.5M +$28.5M +1,349,689 New
DekaBank Deutsche Girozentrale
21
DekaBank Deutsche Girozentrale
Germany
$23.6M -$2.69M -127,685 -10%
Arrowstreet Capital
22
Arrowstreet Capital
Massachusetts
$23.1M +$22.6M +1,073,535 +4,811%
CA
23
Commerzbank Aktiengesellschaft
Germany
$22.5M +$4.84M +229,271 +27%
CIP
24
Champlain Investment Partners
Vermont
$22.4M +$4.64M +220,180 +26%
Renaissance Technologies
25
Renaissance Technologies
New York
$21.7M +$21.7M +1,028,319 New

QGENF Hedge Fund Activity: Q1 2014 in Review

166 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q1 2014, worth a combined $2.27B — down 9.3% from $2.5B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new QGENF positions and 19 closed out — a net gain of 6 holders — while 65 added to existing stakes and 54 trimmed.

The largest buyer was Primecap Management, adding an estimated $60.1M. The largest seller was Credit Agricole, cutting an estimated $55.8M.

  • 166 institutional investors held QIAGEN NV (QGENF) as of Q1 2014, up from 165 in Q4 2013.
  • Funds reported $2.27B of QIAGEN NV stock for Q1 2014, down 9.3% quarter-over-quarter.
  • 25 funds opened new QIAGEN NV positions in Q1 2014 and 19 closed out, a net change of +6 holders.
  • The largest QIAGEN NV buyer in Q1 2014 was Primecap Management, an estimated $60.1M added.
  • The largest QIAGEN NV seller in Q1 2014 was Credit Agricole, an estimated $55.8M sold.

Based on aggregated 13F filings for Q1 2014.